Menu
Peptide Database
Results
No peptides found
Featured

Use search to browse all 100+ peptides

Gonadorelin

GnRH, Luteinizing Hormone-Releasing Hormone, LHRH, Factrel

Quick Stats
Studies 192
Trials 100
Score 1
2025 pubmed

Unraveling Delayed Puberty: A Rare Case of Congenital Hypogonadotropic Hypogonadism Masked by Celiac Disease and Plummer-Vinson Syndrome.

Ahmad. Osama O; Akbar. Uzma U; Sajjad. Fatima F; Ali. Muhammad Abdullah MA; Alam. Umama U; Bacha. Zaryab Z; Ikram. Jibran J; Khan. Malik W Z MWZ

Key Findings

  • CHH can be masked by chronic diseases like celiac and Plummer‑Vinson syndrome.
  • Normal olfactory bulb does not rule out CHH; subtle brain changes may be present.
  • Accurate diagnosis requires hormone panels, genetic testing, and imaging to differentiate from functional delays.
  • Untreated CHH leads to infertility and bone loss, so early hormonal therapy is crucial.

Practical Outcomes

  • If you notice persistent lack of secondary sexual traits, low muscle mass, or other puberty‑related issues, get a full hormone panel and consider imaging even if you have other chronic illnesses. Early detection can allow GnRH‑based treatments (e.g., gonadorelin) under medical supervision to trigger puberty and protect bone health.

Summary

A 25‑year‑old man with celiac disease and Plummer‑Vinson syndrome was found to have congenital hypogonadotropic hypogonadism (CHH), a rare condition that stops puberty because the brain doesn’t release enough GnRH. Even though his sense of smell and brain scans looked normal, his hormone tests and tiny testes showed the problem. The case shows CHH can be hidden behind other illnesses and needs careful testing to avoid missing it.

Abstract

Congenital hypogonadotropic hypogonadism (CHH) is a rare disorder that results in delayed puberty and infertility due to impaired secretion of gonadotropin-releasing hormone (GnRH). Here, we present a case of a 25-year-old male with a known history of Plummer-Vinson syndrome and celiac disease, who presented with the chief complaints of easy fatigability, shortness of breath on exertion, difficulty in swallowing, and no secondary sexual characteristics. Physical examination revealed a pale, thin, and lean male appearing significantly younger than his chronological age with notable findings of microgenitalia, absence of facial and axillary hair, decreased muscle mass, and no deepening of voice. His workup for delayed puberty, including hormonal studies, indicated hypogonadotropic hypogonadism, whereas Genetic testing confirmed a normal male karyotype. U/S scrotum showed bilateral atrophic testes. However, Neuroimaging studies revealed a normal olfactory bulb, no findings of agenesis, and hypoplasia of the olfactory sulcus. Thus, our findings in this case were consistent with and favor the diagnosis of congenital hypogonadotropic hypogonadism, also known as Idiopathic hypogonadotropic hypogonadism. It can be misdiagnosed as functional hypogonadotropic hypogonadism or simple constitutional delay of growth and puberty, especially in the presence of chronic illness. Thus, clinicians should consider CHH as one of the differential diagnoses and adopt a multidisciplinary approach when evaluating patients with delayed puberty. Timely and accurate diagnosis is crucial to initiate appropriate hormonal therapy and prevent long-term complications such as infertility and osteoporosis.

Study Information

Provider

pubmed

Year

2025

Date

2025-09-26T00:00:00.000Z

DOI

10.1002/ccr3.70952

References

11